London-based insurtech startup Marrow has raised $2 million in pre-seed funding to expand its infrastructure platform connecting artificial intelligence agents with insurance providers.
The round was led by Insurtech Gateway, with participation from Seed X Liechtenstein, Leo Capital, Portfolio Ventures and angel investors. The investment was announced on October 22, 2026.
Marrow was co-founded by Tim Graham and Adam Mesout. Graham serves as CEO and previously held the position of Head of Product at Ki, while Mesout serves as CTO and was a founding engineer at Ki. Mesout is also a qualified actuary.
The company develops infrastructure that enables AI assistants to interact with insurers’ existing pricing, underwriting and policy administration systems. Its platform acts as an intermediary between insurance providers and AI-powered applications, allowing agents to access insurance products through a standardised interface.
Marrow’s technology is designed to manage regulatory requirements during AI-mediated insurance interactions. It controls the information agents can access, supports required customer disclosures, applies underwriting rules and maintains audit records of transactions.
The platform is intended to help insurers participate in AI-powered distribution channels while retaining control over their products and customer interactions.
Marrow has been operating in production with UK insurer Aviva since March 2026. The company also published its Agent Mediated Insurance (AMI) Standards in September 2026, providing an open technical framework for AI agents to interact with regulated insurance products.
The new funding will support the expansion of Marrow’s engineering and commercial teams in London, the onboarding of additional retail and commercial insurance providers, and further development of its AMI Standards.
The company plans to advance the standards towards their first full version while working with insurers and other industry participants.

